Is there a future for endovascular treatment of intracranial atherosclerotic disease after Stenting and Aggressive Medical Management for Preventing Recurrent Stroke and Intracranial Stenosis (SAMMPRIS)?

Stroke

Volumn 43, Issue 2, 2012, Pages 580-584

  Marks, Michael P ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

angioplasty and stenting; atherosclerosis; stents

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL;

ARTICLE; BRAIN ATHEROSCLEROSIS; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; DISEASE REGISTRY; ENDOVASCULAR SURGERY; FEMALE; FOLLOW UP; HUMAN; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RISK ASSESSMENT; RISK REDUCTION; STENOSIS; STENT; STENT THROMBOSIS; STROKE; SUBARACHNOID HEMORRHAGE;

BRAIN ISCHEMIA; CONSTRICTION, PATHOLOGIC; ENDOVASCULAR PROCEDURES; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; STENTS; STROKE; TREATMENT OUTCOME;

EID: 84856497245     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.645507     Document Type: Article

References (40)

1. Chimowitz MI, Lynn MJ, Derdeyn CP, Turan TN, Fiorella D, Lane BF, et al. Stenting vs aggressive medical therapy for intracranial arterial stenosis. N Engl J Med. 2011;365:993-1003.
2. Chimowitz MI, Lynn MJ, Turan TN, Fiorella D, Lane BF, Janis S, et al. Design of the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis trial. J Stroke Cerebrovasc Dis. 2011;20:357-368.
3. Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005;352:1305-1316.
4. Kasner SE, Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, et al. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation. 2006;113: 555-563.
5. Stenting vs. Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS). National Institutes of Health. Available at: http://clinicaltrials.gov/ct2/show/study/NCT00576693. Accessed December 9, 2011.
6. Bose A, Hartmann M, Henkes H, Liu HM, Teng MMH, Szikora I, et al. A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: the Wingspan study. Stroke. 2007;38: 1531-1537. (Pubitemid 46684170)
7. Fiorella D, Levy EI, Turk AS, Albuquerque FC, Niemann DB, Aagaard-Kienitz B, et al. US multicenter experience with the Wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results. Stroke. 2007;38:881-887. (Pubitemid 46568447)
8. Zaidat OO, Klucznik R, Alexander MJ, Chaloupka J, Lutsep H, Barnwell S, et al. The NIH registry on use of the Wingspan stent for symptomatic 70-99% intracranial arterial stenosis. Neurology. 2008;70:1518-1524. (Pubitemid 351589505)
9. Levy EI, Turk AS, Albuquerque FC, Niemann DB, Aagaard-Kienitz B, Pride L, et al. Wingspan in-stent restenosis and thrombosis: incidence, clinical presentation, and management. Neurosurgery. 2007;61:644-650; discussion 650-651. (Pubitemid 47442683)
10. Turk AS, Levy EI, Albuquerque FC, Pride GL Jr, Woo H, Welch BG, et al. Influence of patient age and stenosis location on Wingspan in-stent restenosis. AJNR Am J Neuroradiol. 2008;29:23-27.
11. Albuquerque FC, Levy EI, Turk AS, Niemann DB, Aagaard-Kienitz B, Pride GL Jr, et al. Angiographic patterns of Wingspan in-stent restenosis. Neurosurgery. 2008;63:23-27; discussion 27-28.
12. Fiorella DJ, Turk AS, Levy EI, Pride GL Jr, Woo HH, Albuquerque FC, et al. US Wingspan Registry: 12-month follow-up results. Stroke. 2011; 42:1976-1981.
13. Bushnell CD, Olson DM, Zhao X, Pan W, Zimmer LO, Goldstein LB, et al. Secondary preventive medication persistence and adherence 1 year after stroke. Neurology. 2011;77:1182-1190.
14. Daugherty SL, Ho PM, Spertus JA, Jones PG, Bach RG, Krumholz HM, et al. Association of early follow-up after acute myocardial infarction with higher rates of medication use. Arch Intern Med. 2008;168:485-491; discussion 492. (Pubitemid 351547211)
15. De Schryver EL, van Gijn J, Kappelle LJ, Koudstaal PJ, Algra A. Non-adherence to aspirin or oral anticoagulants in secondary prevention after ischaemic stroke. J Neurol. 2005;252:1316-1321. (Pubitemid 41699020)
16. Ho PM, Spertus JA, Masoudi FA, Reid KJ, Peterson ED, Magid DJ, et al. Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med. 2006;166:1842-1847. (Pubitemid 44455166)
17. Melloni C, Alexander KP, Ou FS, LaPointe NM, Roe MT, Newby LK, et al. Predictors of early discontinuation of evidence-based medicine after acute coronary syndrome. Am J Cardiol. 2009;104:175-181.
18. Mori T, Fukuoka M, Kazita K, Mori K. Follow-up study after intracranial percutaneous transluminal cerebral balloon angioplasty. AJNR Am J Neuroradiol. 1998;19:1525-1533. (Pubitemid 30431049)
19. Qureshi AI, Tariq N, Hassan AE, Vazquez G, Hussein HM, Suri MF, et al. Predictors and timing of neurological complications following intracranial angioplasty and/or stent placement. Neurosurgery. 2010;68: 53-60; discussion 60-51.
20. Suh DC, Kim JK, Choi JW, Choi BS, Pyun HW, Choi YJ, et al. Intracranial stenting of severe symptomatic intracranial stenosis: results of 100 consecutive patients. AJNR Am J Neuroradiol. 2008;29:781-785. (Pubitemid 351596115)
21. Kurre W, Berkefeld J, Brassel F, Bruning R, Eckert B, Kamek S, et al. In-hospital complication rates after stent treatment of 388 symptomatic intracranial stenoses: results from the INTRASTENT multicentric registry. Stroke. 2010;41:494-498.
22. Zhu SG, Zhang RL, Liu WH, Yin Q, Zhou ZM, Zhu WS, et al. Predictive factors for in-stent restenosis after balloon-mounted stent placement for symptomatic intracranial atherosclerosis. Eur J Vasc Endovasc Surg. 2010;40:499-506.
23. Miao ZR, Feng L, Li S, Zhu F, Ji X, Jiao L, et al. Treatment of symptomatic middle cerebral artery stenosis with balloon-mounted stents: long-term follow-up at a single center. Neurosurgery. 2009;64:79-84; discussion 84-85.
24. Al-Ali F, Cree T, Hall S, Louis S, Major K, Smoker S, et al. Predictors of unfavorable outcome in intracranial angioplasty and stenting in a single-center comparison: results from the Borgess Medical Center-Intracranial Revascularization Registry. AJNR Am J Neuroradiol. 2011; 32:1221-1226.
25. Jiang WJ, Cheng-Ching E, Abou-Chebl A, Zaidat OO, Jovin TG, Kalia J, et al. Multi-center analysis of stenting in symptomatic intracranial atherosclerosis. Neurosurgery. 2011;70:25-31.
26. Marks MP, Marcellus M, Norbash AM, Steinberg GK, Tong D, Albers GW. Outcome of angioplasty for atherosclerotic intracranial stenosis. Stroke. 1999;30:1065-1069. (Pubitemid 29211628)
27. Wojak JC, Dunlap DC, Hargrave KR, DeAlvare LA, Culbertson HS, Connors JJ III. Intracranial angioplasty and stenting: long-term results from a single center. AJNR Am J Neuroradiol. 2006;27:1882-1892. (Pubitemid 44556503)
28. Marks MP, Wojak JC, Al-Ali F, Jayaraman M, Marcellus ML, Connors JJ, et al. Angioplasty for symptomatic intracranial stenosis: clinical outcome. Stroke. 2006;37:1016-1020.
29. Nguyen TN, Zaidat OO, Gupta R, Nogueira RG, Tariq N, Kalia JS, et al. Balloon angioplasty for intracranial atherosclerotic disease: periprocedural risks and short-term outcomes in a multicenter study. Stroke. 2011;42:107-111.
30. Fiorella D, Chow MM, Anderson M, Woo H, Rasmussen PA, Masaryk TJ. A 7-year experience with balloon-mounted coronary stents for the treatment of symptomatic vertebrobasilar intracranial atheromatous disease. Neurosurgery. 2007;61:236-242; discussion 242-233. (Pubitemid 47357287)
31. Jiang WJ, Xu XT, Du B, Dong KH, Jin M, Wang QH, et al. Comparison of elective stenting of severe vs moderate intracranial atherosclerotic stenosis. Neurology. 2007;68:420-426. (Pubitemid 46208744)
32. Kurre W, Brassel F, Bruning R, Buhk J, Eckert B, Horner S, et al. Complication rates using balloon-expandable and self-expanding stents for the treatment of intracranial atherosclerotic stenoses: Analysis of the INTRASTENT multicentric registry. Neuroradiology. Epub ahead of print January 11, 2011. DOI: 10.1007/s00234-010-0826-y.
33. VISSIT Intracranial Stent Study for Ischemic Therapy. National Institutes of Health. Available at: http://clinicaltrials.gov/ct2/show/NCT00816166. Accessed December 9, 2011.
34. Siddiq F, Vazquez G, Memon MZ, Suri MF, Taylor RA, Wojak JC, et al. Comparison of primary angioplasty with stent placement for treating symptomatic intracranial atherosclerotic diseases: A multicenter study. Stroke. 2008;39:2505-2510.
35. Natarajan SK, Ogilvy CS, Hopkins LN, Siddiqui AH, Levy EI. Initial experience with an everolimus-eluting, second-generation drug-eluting stent for treatment of intracranial atherosclerosis. J Neurointerv Surg. 2010;2:104-109.
36. Gupta R, Al-Ali F, Thomas AJ, Horowitz MB, Barrow T, Vora NA, et al. Safety, feasibility, and short-term follow-up of drug-eluting stent placement in the intracranial and extracranial circulation. Stroke. 2006; 37:2562-2566. (Pubitemid 44454680)
37. Steinfort B, Ng PP, Faulder K, Harrington T, Grinnell V, Sorby W, et al. Midterm outcomes of paclitaxel-eluting stents for the treatment of intracranial posterior circulation stenoses. J Neurosurg. 2007;106:222-225. (Pubitemid 46203146)
38. Qureshi AI, Kirmani JF, Hussein HM, Harris-Lane P, Divani AA, Suri MF, et al. Early and intermediate-term outcomes with drug-eluting stents in high-risk patients with symptomatic intracranial stenosis. Neurosurgery. 2006;59:1044-1051; discussion 1051. (Pubitemid 44852090)
39. Vajda Z, Guthe T, Aguilar Perez M, Heuschmid A, Schmid E, Bazner H, et al. Neurovascular in-stent stenoses: treatment with conventional and drug-eluting balloons. AJNR Am J Neuroradiol. Epub ahead of print September 1, 2011. DOI: 10.3174/ajnr.A2644.
40. Qureshi AI. Interpretation and implications of the prematurely terminated Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) Trial. Neurosurgery. 2011; 70:e264-e268.